Want the short version?
Ask OQRO reads the filings behind this page and answers in plain words, with a link to each source.
Ask OQRO is part of OQRO Pro. Everything else on OQRO is free.
Ask OQRO reads the filings behind this page and answers in plain words, with a link to each source.
Ask OQRO is part of OQRO Pro. Everything else on OQRO is free.
Only to see which pages are hard to use, so we can fix them. Nothing is used for ads, and what you type stays hidden (Microsoft Clarity, PostHog). Privacy Policy
The latest available 13F covers holdings as of Jun 30, 2026 (Q2 2026) and was filed Aug 14, 2026. Quarter-end snapshot, not a live trade.
Disclosed 13F value
$5.32B
sum of reported positions
Reported positions
737
Changes vs prior quarter
737
326 new · 57 exited
Filings on record
8
Q2 2026, Q1 2026, Q4 2025, Q3 2025, Q2 2025, Q1 2025, Q4 2024, Q2 2024
Across 192 measured positions in 6 quarters, the typical new or larger position finished −3.0 pts against the S&P 500 and 44% finished ahead of it. For scale, across all 501 funds with a result: −2.2 pts typical, 44% ahead.
Measured on each position this fund reported as new or larger, from the first close after the filing became public, against the S&P 500, 90 days later. Sales are not scored. History, not a forecast; it shows what the stocks did, not what the fund knew.
Total value of the 13F each quarter. It moves with prices as well as with what the fund bought or sold, so a rise is not necessarily a purchase.
| Company | Shares | Value | Weight |
|---|---|---|---|
| 214K | $79.8M | 1.5% | |
| 223K | $76.5M | 1.4% | |
| 1.05M | $75.7M | 1.4% | |
Comparison uses this manager's immediately preceding 13F-HR. Puts and calls are separate lines. Share counts drive classification; reported value also moves with price.Methodology
Change in the reported value against the quarter before.
Weights are within the disclosed 13F portfolio, for the ten largest lines.
| Q1 2026 | Q2 2026 | |
|---|---|---|
| Reported value | $2.67B | $5.32B |
| Positions | 468 | 737 |
| Biggest line | — | GE Aerospace 2% |
| 324K |
| $72.6M |
| 1.4% |
| 324K | $72.2M | 1.4% |
| 387K | $71.6M | 1.3% |
| 206K | $70.1M | 1.3% |
| 72K | $69.1M | 1.3% |
| 183K | $68.3M | 1.3% |
| 51K | $67.7M | 1.3% |
| 132K | $67.6M | 1.3% |
| 188K | $66.7M | 1.3% |
| 205K | $64.3M | 1.2% |
| 131K | $64.2M | 1.2% |
| 133K | $60.4M | 1.1% |
| 302K | $58.7M | 1.1% |
| 1.3M | $56.3M | 1.1% |
| 219K | $55.8M | 1.1% |
| 1.06M | $52.8M | 1.0% |
| 120K | $51M | 1.0% |
| 288K | $50.8M | 1.0% |
| 187K | $48.6M | 0.9% |
| 385K | $47.1M | 0.9% |
| 1.04M | $46.9M | 0.9% |
| 139K | $45.4M | 0.9% |
Infinity Natural Resources (INR)
29K shares
Urban Edge Properties (UE)
16K shares
Orrstown Financial Services (ORRF)
13K → 8,911 shares (−33%)
Winnebago Industries, Inc. (WGO)
12K shares
Microvast Holdings (MVST)
519K → 309K shares (−41%)
Univest Financial (UVSP)
8,184 shares
Orion Group (ORN)
23K → 21K shares (−7%)
Eve Holding (EVEX)
141K shares
LivaNova (LIVN)
4,290 shares
California Bancorp (BCAL)
35K → 17K shares (−53%)
Nurix Therapeutics (NRIX)
14K shares
Tompkins Financial Corporation (TMP)
3,600 shares
Graham (GHM)
2,715 shares
Tyra Biosciences (TYRA)
10K shares
Solid Biosciences (SLDB)
33K shares
Sprinklr, Inc. (CXM)
249K → 63K shares (−75%)
Resources Connection (RGP)
88K → 76K shares (−13%)
Nabors Industries (NBR)
2,611 → 3,819 shares (+46%)
Consensus Cloud Solutions (CCSI)
8,408 shares
Citi Trends (CTRN)
5,464 shares
Nn (NNBR)
87K shares
Crispr Therapeutics (CRSP)
5,702 shares
Capital Bancorp (CBNK)
8,825 shares
Franklin Financial Services Corp (FRAF)
5,006 → 4,906 shares (−2%)
MYR Group, Inc. (MYRG)
604 shares